American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Genetics Today

November 17, 2020 12:00 pm CT

Genetic testing to assess cancer risk may be necessary when a personal or family history suggests an inherited cancer risk condition. As information changes and treatment evolves, additional patients may need testing, counseling, and to learn about better treatment options. The speakers will discuss recent advances in genetic testing, counseling, and treatment of patients with breast cancer as well as changes made to their NAPBC-accredited breast centers that are addressing patient needs.

Moderator

Bill Laffey, MBA, COA

Bill Laffey, MBA

Mr. Laffey, MBA, COA, is currently president of The Laffey Partnership, an oncology management and accreditation consulting firm. A former hospital Chief Executive Officer, his most recent positions include system vice president of oncology at a 12-hospital system in Illinois and a similar position at a 15-hospital system in Wisconsin. Mr. Laffey earned his MBA from the University of Chicago, and has authored oncology-related articles and spoken at numerous conferences, both nationally and internationally. He is Past President of the Association of Cancer Executives and has been a Commission on Cancer Site Reviewer since 2012. He was the 2020 recipient of the Marsha Fountain Award for Excellence in Oncology Administration.


Panelists

Catherine Pesce, MD, FACS

Catherine Pesce, MD, FACS

Dr. Pesce is a surgical oncologist specializing in breast cancer and breast surgery. She is the director of the Breast Surgical Program at NorthShore University Health System and is a Clinical Associate Professor at the University of Chicago Pritzker School of Medicine. Dr. Pesce went to Duke University as an undergraduate and received her medical degree from Rush Medical College. She completed her general surgery internship and residency at Johns Hopkins in Baltimore, MD and completed a breast surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York, NY. She has research interests in young women with breast cancer, surgical decision making, and quality-of-life issues involved in breast cancer surgery, and most recently she became the program director of the Breast Surgery Fellowship at NorthShore. She is delighted to have the opportunity to present her work with you today.


Keisa  Mansfield, MPA

Keisa Mansfield, MPA

Ms. Mansfield is the manager of Clinical Research and Genetics at the Phoebe Cancer Center. She serves as the primary point of contact for all clinical research activities for the Phoebe Putney Health System. Ms. Mansfield provides leadership and continuity in all research, control, screening efforts, and grant development projects. Previously, she served as the Research Program Manager for Georgia Cancer Research at Phoebe providing administrative oversight and coordination for the implementation of multiple community-based cancer research studies and activities.

Ms. Mansfield has more than 20 years of community-based research experience that targets the underserved and disadvantaged populations in southwest Georgia. Prior to joining Phoebe, she was a public health liaison for the Southwest Public Health District and adjunct faculty at Albany State University in the College of Business Healthcare Management Program.


Theresa Weiss, MSN, RN

Theresa Weiss, MSN, RN

Ms. Weiss is a nurse at Phoebe Cancer Center where she facilitates the genetic testing program and the breast health center’s High-Risk Breast Program. She has been a nurse for more than 30 years, working in a variety of areas including medical/surgical nursing, inpatient rehabilitation, ambulatory care, and quality management. While working in all of these areas, it can be hard to see one’s personal impact. Working at Phoebe Cancer Center, Ms. Weiss knows the work she is doing is meaningful to so many, whether their testing outcomes show a predisposition for cancer(s) or not. She has the perfect personality to be a calming resource and advocate for each type of patient—which can be a hard balance to achieve.


Karen Karsif, MD

Karen Karsif, MD

Dr. Karsif is a board-certified surgeon with more than 20 years of experience devoted entirely to treating breast disease. She is currently the medical director at the Center for Breast Health at Good Samaritan Hospital in Suffern, NY. She received her medical degree from the University of Pennsylvania School of Medicine in Philadelphia and completed her internship at Pennsylvania Hospital in Philadelphia. Dr. Karsif finished her surgical residency at Albert Einstein Medical Center in Philadelphia. She is known among her patients and colleagues for providing quality and compassionate care. In fact, the Susan G. Komen Foundation honored Dr. Karsif with the Gay Clark Stoddard Memorial Award in recognition of the level of care she brings to her patients every day. She is honored to share some of the progressive initiatives in high risk screening her team has implemented.


Learning Objectives

  • Describe recent changes to genetic testing, counseling, surveillance, and the effect on patients with breast cancer. Describe changes to the care process to make new services available to patients.
  • Discuss new treatment options available to patients with breast cancer that may be caused by a genetic mutation and improvements made to bring these options to patients.
  • Compare and contrast the experiences in a variety of health care settings and use the information to design evaluations and interventions to address the genetic testing and counseling needs in their own NAPBC-accredited center.

Target Audience

The NAPBC Best Practices webinar series is for all members of the multidisciplinary care team at health care facilities that treat patients with cancer and diseases of the breast, including but not limited to: 

  • Cancer committee members
  • Navigators
  • Nurses
  • Physicians
  • Program leadership (cancer program administrators, breast program directors, breast program leaders)
  • Registrars

Continuing Education

A Certificate of Completion will be awarded for this course.

1 continuing education credit for #2020-147 will be provided from National Cancer Registrars Association (NCRA).

ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437, for 1 contact hour.